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Research progress into mechanisms of the anaerobe Clostridium perfringens and
associated diseases has been frustrated by the lack of reliable infection models.
Wax moth larvae (Galleria mellonella) have emerged as a viable alternative to other
models of infection since they are economic, survive at 37◦C and require no specialist
equipment. This study aims to establish to what extent G. mellonella larvae can be
used to study the virulence of C. perfringens strains and its suitability for studying novel
treatment strategies by an improved time-lapse approach to data collection. Mortality
and morbidity rates of larvae challenged with 105 CFU of C. perfringens isolates
from various sources were observed over 72 h and dose response data obtained.
Phenoloxidase enzyme activity was investigated as a marker for immune response
and tissue burden assessed by histopathological techniques. Results demonstrate that
C. perfringens is pathogenic toward G. mellonella although potency varies dramatically
between C. perfringens isolates and the reference strain ATCC 13124 was shown to
be avirulent. Infection with C. perfringens strains activated the melanisation pathway
resulting in melanin deposition but no increase in enzyme activity was observed. Efficacy
of antibiotic therapy (penicillin G, bacitracin, neomycin, and tetracycline) administered
parenterally to some extent correlates with that of in vitro analysis. The findings suggest
G. mellonella might be a useful in vivo model of infection and convenient as a pre-
screening assay for virulence of C. perfringens strains or as a simple, cheap and rapid
in vivo assay in the first stage development of novel therapeutics against anaerobes.
HIGHLIGHTS
- Potential novel in vivo model for the study of Clostridium perfringens infection.
- Novel time-lapse approach to data collection.
- First report of the pathogenicity of C. perfringens toward G. mellonella.
- First report of the efficacy of antibiotic therapy in response to C. perfringens infection
in G. mellonella.
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INTRODUCTION
Insect models have been shown to be helpful in our
understanding of the virulence of bacterial pathogens in
humans (Tsai et al., 2016). Insects share some similarities with
mammalian processes and possess a basic innate immune system
(Ramarao et al., 2012). Alternative model organisms such as
the zebra fish (Danio rerio), silkworm (Bombyx mori), tobacco
hornworm (Manduca sexta), fruit fly (Drosophila melanogaster),
and nematodes (Caenorhabditis elegans) (Browne et al., 2013) are
not associated with the same ethical considerations as in the use
of higher vertebrates (Peterson et al., 2008). The larval stage of
the Greater Wax moth (Galleria mellonella) has emerged as an
insect model of particular value since it survives at 37◦C, which
is essential for demonstration of specific microbial virulence
factors (Smoot et al., 2001).
The larvae are inexpensive to obtain and easy to maintain
using basic equipment (Ramarao et al., 2012). The model
does not require ethical approval and coupled with fast
reproduction time, allows for a high-throughput of experiments
compared with mammalian systems. Whilst G. mellonella has
not evolved an adaptive immune response, they possess a
semi-complex cellular and humoral innate immunity. This innate
system, in insects, shares remarkable similarities to that of
mammals (Jander et al., 2000). The cellular immune response
in the larvae consists of haemocytes which play a role in
phagocytosis, encapsulation and clotting as an antimicrobial
response (Tojo et al., 2000). The humoral response consists of
various antimicrobial peptides, opsonins, extracellular nucleic
acid traps and the phenol-oxidase pathway as described recently
in detail by Tsai et al. (2016).
Development of infection models with G. mellonella larval
hosts has involved a diverse range of microbes including:
Cryptococcus neoformans (Mylonakis et al., 2005), Burkholderia
cepacia (Seed and Dennis, 2009), Yersinia pseudotuberculosis
(Champion et al., 2009) Acinetobacter baumannii (Peleg et al.,
2009), Campylobacter jejuni (Senior et al., 2011), Candida
albicans (Brennan et al., 2002), Legionella pneumophilia,
(Harding et al., 2013), Pseudomonas aeruginosa (Beeton et al.,
2015), Mycobacterium fortuitum (Entwistle and Coote, 2018),
and Vibrio parahaemolyticus (Wagley et al., 2017). In the
present study, we have investigated the pathogenicity of
C. perfringens in G. mellonella larvae. C. perfringens is a
ubiquitous Gram-positive, spore-forming, anaerobic bacilli,
classically characterized by four major extracellular toxins:
alpha (cpa), beta (cpb), epsilon (etx), and iota (iA). Recently
necrotic enteritis-like B toxin (netB) and enterotoxin (cpe) has
been added to the classification system (Table 1; Rood et al.,
2018). The bacteria produce a plethora of non-typing toxins
including haemolysin, perfringolysin O (pfoA), collagenase (colA)
(Songer, 1996), beta2 toxin (cpb2) (Van-Asten et al., 2010),
and binary enterotoxin A and B (becA and becB) (Yonogi
et al., 2014) with differing and elusive roles in the bacterial
mode of infectivity.
Clostridium perfringens is one of the leading food borne
pathogens in the United Kingdom and worldwide. It is
implicated in 80–95% of reported gas gangrene cases (Titball,
TABLE 1 | Toxin type classification system for C. perfringens.
Type Alpha Beta Epsilon lota Entero-toxin netB∗
A + − − − − −
B + + + − − −
C + + − +/− −
D + − + − +/− −
E + − − + +/− −
F + − − − + −
G + − − − − +
Isolates are characterized by the production of one, or more, of the now six major
toxins: alpha, beta, epsilon, iota, ∗necrotic enteritis like B and enterotoxin. Alpha
toxin is produced by all types of C. perfringens (Rood et al., 2018).
2005) and causes large economic losses in the agricultural
industry (Wade et al., 2015). Research into this important
bacterial pathogen has been slowed by the lack of standardized
disease models for assessing virulence and in vivo susceptibility
to antimicrobial drugs. The G. mellonella larvae model of
infection is developing as an alternative screening method for
economically progressing novel antimicrobial compounds prior
to mammalian studies.
To date, no detailed reports of C. perfringens infection models
with G. mellonella have been published. It should be noted,
however, that Champion et al. (2016) highlights an unpublished
report suggesting alpha and enterotoxin from C. perfringens
lack toxicity against the larvae. The aim of this study was to
establish the extent of G. mellonella susceptibility to C. perfringens
infection as a basis for further virulence studies. This present
study investigates the susceptibility to 15 distinct C. perfringens
isolates from United Kingdom environmental sources including
a standard reference strain and explores the response of
the larvae to traditional antibiotic therapy. In addition, we
introduce a novel imaging capture and time-lapse methodology
designed to increase accuracy whilst easily monitoring larval
disease progression.
MATERIALS AND METHODS
Bacterial Strains and Preparation of
Inoculum
Clostridium perfringens was sourced from our culture collection
and isolates selected based on toxin profiles (Table 2; Sim
et al., 2015). Cultures were stored in 30% glycerol (Thermo
Fisher Scientific, United Kingdom), 70% brain heart infusion
(BHI) media (Oxoid, United Kingdom) at −80◦C and cultured
on BHI agar (Oxoid, United Kingdom). Liquid cultures were
grown to mid-log phase, in BHI or thioglycollate broth (FTG)
(Oxoid, United Kingdom) and incubated at 37◦C for 5 h.
Bacterial inocula were adjusted by absorbance (OD620) and
CFU/mL determined by traditional serial dilution and plating
on TSC agar (Oxoid, United Kingdom). Cells in adjusted
cultures were pelleted by centrifuging at 3170 × g at room
temperature for 2 min (Heraeus Megafuge 8) and washed once
with 0.1% peptone water (Oxoid, United Kingdom). Dilutions
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TABLE 2 | Clostridium perfringens toxin profiles of strains and isolates used within this study.
Isolate Source cpa cpb etx iA cpe netb cpb2 pfoA tpeL colA becA becB cna Type
JBFR014 Free Range Chicken + − − − − − − − − − − − − A
ATCC 13124 Type Strain + − − − − − − + − + − − − A
LPCP001 Sheep + − − − − − − + − + − − − A
LPCP023 Sheep + − − − − − − + − + − − − A
LPCP042 Sheep + − − − − − − + − + − − − A
EDCB283 Retail Chicken + − − − − + + + − + − − − G
EDCB093 Retail Chicken + − − − − − − + + + − − − A
JBRC013 Broiler + − − − − + − − − + + − − G
JBCNJ58 Broiler + − − − − + − + − + − − − G
JBCNCR03 Broiler + − − − − + − + + + − − − G
JBCNC055 Broiler + − − − − − + + − + − − − A
JBCND021 Broiler + − − − − + + + − + − − − G
JBCNI050 Broiler + − − − − − − − − − − − − A
JBCND053 Broiler + − − − − − − + − + − − − A
JBCNJ055 Broiler + − − − − − + + − + − − − A
were drawn into a 1 mL syringe fitted with a 30 g sterile
needle (BD plastipak).
Galleria mellonella Challenge Assay
Larvae were purchased from Live Foods United Kingdom
(Rooks Bridge, United Kingdom). Upon arrival, they were
stored in wood shavings, at room temperature, in the dark. To
avoid sampling biases, larvae with any signs of melanisation
or deformity were rejected. Larvae were weighed and only
larvae meeting the criteria of 250 ± 50 mg were utilized.
Prior to all injections, larvae were immobilized by standing the
24 micro-well plate (Thermo Fisher Scientific, United Kingdom)
on ice for 15 min. An automated syringe pump (KD Scientific,
United States) was supplied with the drawn 1 mL syringes
and set to administer 1 µL/s for 10 s (Figure 2B). A safety
restraint device was used, outlined by Dalton et al. (2017)
(Figure 2C). To minimize adverse effects, larvae were injected
into the right posterior proleg (Figure 2C). A melanisation
scoring system adapted from Senior et al. (2011) is shown
in Figure 1 and employed throughout. Results were obtained
longitudinally with a novel image capture system (Figure 2A).
Briefly, the system was constructed with a benchtop incubator,
with transparent sides and top (Stuart Scientific SI140).
Images were recorded by a Logitech 15 MP camera coupled
with time-lapse software (SkystudioPro) (Figure 2D). For
each experiment, images of the larvae were recorded every
10 min for 72 h.
Pathogenicity Screening
Fifteen C. perfringens isolates from poultry, goats and their
environments along with ATCC 13124 (Table 2) were prepared
for inoculation as described above. Groups of 10 larvae were
each challenged with 10 µl of 107 CFU/mL and each experiment
included 10 larvae injected with 0.1% peptone water as controls.
Larvae were placed in Petri-dishes lined with greaseproof paper
to allow for greater contrast in images. All groups were incubated
aerobically at 37◦C and survival recorded at 72 h p.i. The
experiments were repeated in triplicate and an average survival
result recorded.
Dose Dependent Challenge
In dose dependent challenge studies, larvae were prepared by
placing one per well in 24 micro-well plastic plates (Thermo
Fisher Scientific, United Kingdom). All larvae were treated
identically to ensure injection and isolate continuity throughout.
ATCC 13124, JBFR014, and JBCNJ055 were investigated by
preparing a dilution series of each isolate and larvae were injected
with a dilution of 10 µL of washed cultures ranging from
approximately 103 to 107 CFU/mL. In addition, 24 larvae were
injected with 10 µL of 0.1% peptone water as negative controls.
All six plates for each isolate were recorded simultaneously with
the image recording system described previously. The larvae were
incubated for 72 h at 37◦C. Images were taken every 10 min for
72 h. Melanisation scores and mortality were recorded at 0,12, 24,
36, 48, 60, and 72 h post injection. All experiments were repeated
in triplicate and average scores recorded.
Soluble Virulence Factor Trial
JBCNJ055, EDCB0283, EDCB093, and JBCND053 (Selection
based on distinct toxin profiles or sources) were used in cell
free trials. 100 µl of overnight culture, of each isolate was
inoculated in 5 mL of FTG (Oxoid, United Kingdom) and
incubated at 37◦C for 5 h. The culture was centrifuged at
3170 × g (Heraeus Megafuge 8) for 3 min and 1 mL of the
supernatant was transferred to a 1.5 mL microcentrifuge tube
(Eppendorf, United Kingdom). The remaining supernatant was
removed from the bacterial pellet and discarded. The pellet was
resuspended in 3 mL of sterile FTG (Oxoid, United Kingdom)
and 1 mL of the resuspended culture transferred to a 1.5 mL
microcentrifuge tube. The contents of each microcentrifuge tube
were drawn into separate 1 mL sterile syringes (BD Plastipak)
and fitted with a 30 g needle. Ten larvae were challenged with
10 uL of each inoculate, from each isolate and were placed
in sterile Petri-dishes lined with greaseproof paper (for better
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FIGURE 1 | Melanisation scoring system adapted from Senior et al. (2011).
contrast in images). The plates were incubated at 37◦C for
72 h. Survival percentages were recorded, and each experiment
repeated in triplicate.
Isolate Selection for Further Analysis
Clostridium perfringens JBCNJ055 was selected as a typical recent
isolate obtained from a broiler chicken with putative necrotic
enteritis in the United Kingdom. Both JBFR014 and JBCNJ055
have been studied extensively in our laboratory and are scheduled
to be DNA sequenced. ATCC 13124 was used as a standard
reference strain. The remaining isolates used in this study
currently have no further characterization.
Haemolymph Extraction
Twelve larvae were challenged with 10 µL of approximately
107 CFU/mL of C. perfringens JBCNJ055 washed culture and 12
larvae injected with 10 µL of 0.1% peptone water as controls.
All larvae were incubated at 37◦C simultaneously for 72 h. At
24 h intervals post challenge, three larvae from each group
were placed into separate sterile 15 mL centrifuge tubes and
submerged in ice for 15 min to immobilize. Haemolymph
was extracted by removing the posterior two segments and
bleeding into a sterile pre-chilled 1.5 mL micro centrifuge tube
(Eppendorf, United Kingdom). 25 µL of extracted haemolymph
was transferred into 75 µL of 50 mM PBS (pH 6.5) (Gibco,
United Kingdom) then briefly vortexed and centrifuged to pellet
the cells at 11,180 × g for 10 min at 4◦C. The supernate was
transferred into sterile 1.5 mL tubes. Samples were processed
within 15 min of extraction to avoid rapid melanisation.
Phenoloxidase Activity
Phenoloxidase activity was measured using a microplate enzyme
assay (Eleftherianos et al., 2008). Briefly, a reaction mixture
containing 115 µL of 50 mM PBS (pH 6.5) and 10 µL
haemolymph plasma was prepared. 25 µL of 20 mM 4-methyl
catechol (Sigma, United Kingdom) was added as enzyme
substrate and 2 µL of 10 mM Escherichia coli LPS (Sigma,
United Kingdom) was added to controls. Plates were subjected
to 1 h of low agitation (25 rpm) at room temperature to
activate endogenous pro-phenol-oxidase prior to addition of
the substrate. The change in absorbance was read at 490 nm
for 1 h at room temperature with a reading taken every 60 s
using a plate reader (Fluostar Optima). Each reaction was
repeated in triplicate.
Histopathology of Galleria Samples
Groups of three larvae were injected with 10µL of approximately
107 CFU/mL of C. perfringens JBCNJ055 and incubated at 37◦C
for 72 h. Control groups were injected with 10 µL of 0.1%
peptone water. At 36 h post injection, larvae were immobilised by
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FIGURE 2 | (A) Schematic of the imaging setup used to record time-lapse
photography of larvae 1: Black felt shroud to reduce the effects of natural light
on quality of images; 2: Camera: Logitek C100 5 mp; 3: table lamp for
consistent lighting; 4: perspex incubator: Stuart Scientific SI140; 5:
Greaseproof paper for better contrast in images. (B) Automated syringe pump
setup used for inoculating larva. (C) Injections were administered through the
rear pro-leg. (D) Example of image output from SkyStudio Pro time-lapse
software.
submerging in ice for 15 min. Larvae were injected with 150 µL
of 10% neutral buffered formalin (Thermo Fisher Scientific,
United Kingdom) (for internal fixation) until turgid and stored
in 10% neutral buffered formalin for 36 h prior to routine tissue
processing. Larvae were dissected completely along the sagittal
plane, and both halves embedded into wax blocks. Tissue sections
(5 µm) were cut by routine methods, mounted on glass slides
and stained with either H+E, Masson Fontana, or Gram stains.
Sections were imaged using light microscope (Zeiss Primostar)
and a 1080 p camera (Mitotic).
MIC Determination
Clostridium perfringens isolate JBCNJ055 was sub-cultured in
10 mL of thioglycollate broth (Oxoid, United Kingdom) and
incubated for 6 h, aerobically at 37◦C. Broth dilution MIC assays
were produced in microtiter plates and prepared with ranges
from 128 to 0.25 µg/mL of penicillin G, bacitracin, tetracycline
and neomycin. MICs were recorded as the lowest concentration
of antimicrobial agent that completely inhibits growth turbidity
compared with positive controls where antibiotics were omitted.
MIC testing was repeated in triplicate on three occasions.
Antibiotic Therapy
The same “batch” of larvae (LiveFoods, United Kingdom) were
employed for each antibiotic therapy experiment. As positive
controls, 24 larvae were challenged with 10 µL of approximately
107 JBCNJ055 culture followed by an injection of 10 µL of
sterile dH2O. A further 24 larvae were injected with 10 µL of
the same inoculum with a second 10 µL injection of either
penicillin G (2 mg/kg), bacitracin (64 mg/kg), tetracycline
(64 mg/kg), or neomycin (2400 mg/kg); concentrations injected
are shown in Table 3. Treatment injections were administered
within 15 min of the bacterial injection. Dosages were chosen
to equate with greater than 10 × in vitro MIC. All larvae
were subjected to toxicity testing with the maximum doses
prior to therapy trials, no melanisation or death was observed.
Finally, 24 larvae were injected with 10 µL 0.1% peptone water
as negative controls (Oxoid, United Kingdom). Larvae were
incubated simultaneously at 37◦C for 72 h. Morbidity and
mortality scores were recorded at 0, 12, 24, 36, 48, 60, and 72 h
post injection. All experiments were repeated in triplicate and
average scores recorded.
Statistical Analysis
The data from each repeat was pooled. Analysis for dose
dependent challenges was conducted using Kaplan–Meier
survival distributions and tested for statistical significance using
the Log rank (Mantel Cox) test (pooled over strata). Mann–
Whitney test was used to highlight statistical significance unless
stated otherwise. All tests were carried out in SPSS, 24 (IBM).
RESULTS
Isolate Pathogenicity
Figure 3 highlights the variability seen in pathogenicity against
G. mellonella with different isolates of C. perfringens. The
TABLE 3 | In vitro MIC results with associated therapeutic dosage.
Treatment In vitro
MIC
(µg/mL)
> × 10
(µg /mL)
Antibiotic
dosage × 100
(µg/mL)
Final larval
Dosage
(µg/larva)
Larval survival
(% ± SD)
+ Control 0 73.61 ± 6.36
− Control 0 100 ± 0
Penicillin G 0.18 5 500 5 68.06 ± 15.77∗
Bacitracin 1.56 15.6 1600 16 94.45 ± 4.8∗
Neomycin 60 600 60,000 600 65.28 ± 18.78
Tetracycline 1.56 15.6 1600 16 79.17 ± 14.43
Survival percentages ± Standard deviation after 72 h of being treated with 10 µL injected doses of 10 × in vitro MIC against 10µL injection of 107 JBCNJ055. “+”
indicates no treatment administered. “−” indicates infection with 0.1% peptone water as trauma controls. ∗Significantly different when compared to + control (P > 0.05)
(Man–Whitney U-test).
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FIGURE 3 | Average survival percentage at 72 h incubation for G. mellonella infected with 10 µL of 107 CFU/mL of respective isolates. Error bars indicate standard
error. Results indicate a variance in lethality of C. perfringens infection toward G. mellonella. ∗ = Mann–Whitney U-test comparing larval survival to uninfected control.
isolates exhibit a varying degree of pathogenicity with cumulative
survival from 5 to 100%.
Parenteral injection of 105 CFU C. perfringens JBCNJ055
resulted in disease of the larvae. Larvae which succumb to the
infection exhibited nodulation, blackening of the cuticle, and
eventually death. Figure 4 shows the rate of development of
infection appears dependent on inoculum size as melanisation
score increases rapidly with increasing inoculum doses of
C. perfringens JBCNJ055. Kaplan–Meier survival distributions
for each bacterial inoculum were significant when compared
using the log-rank (Mantel-Cox) test (pooled over strata)
(P < 0.001). Survival probability appears dependent on the
number of organisms injected (Figure 5). An inoculum size
of 105 CFU/larvae was required for 73.3 ± 6.66% survival
and induced melanisation (>3) in >80% of the population.
104 CFU/larva produced 79.2± 7.2% survival, however,<30% of
the population exhibit melanisation scores higher than 2. Further
dilutions (103; 102; 10) produced >90% survival. Injection
with 105 CFU/Larva of JBFR014 did incite melanisation in
∼40% of the population, however, survival remained at >90%.
Injection with lower dilutions (103; 102; 10) resulted in no visible
blackening of the larvae. Interestingly, injection with 10 µL of
107 CFU/mL ATCC 13124 C. perfringens did not cause visible
disease to the larvae within the 72 h window investigated.
Melanisation did occur at the site of injection, however,
no further immune response was visually observed. Survival
remained above 95% at each inoculum group investigated.
Phenoloxidase
The results of the phenoloxidase assays shows differences
between the control and inoculated groups but not at a significant
difference level. Infected groups demonstrated a melanisation
score of 3 ± 0.8 at 48 h post inoculation compared to no
melanisation in 0.1% peptone controls.
Cell-Free Toxicity
All washed harvested cells of C. perfringens isolates tested
were shown to cause disease in larvae with varying degrees
of potency. Furthermore cell-free supernatants of these isolates
appeared as potent or demonstrated increased potency compared
to uninfected controls of larvae (Figure 6).
Histopathology of Galleria Samples
Figure 7 shows a distinct response of larvae to C. perfringens
demonstrating aggregation and nodulation of haemocytes
compared to uninfected controls There is clear loss of structure
and tissue damage in samples which had been injected
with 105 CFU/Larva of C. perfringens JBCNJ055, with an
abundance of melanin demonstrated by Masson Fontana staining
compared with negative uninfected controls. Gram-positive cells
characteristic of Clostridia were observed associated with tissue
remnants in larval sections from C. perfringens infected larvae.
Antibiotic Therapy
No melanisation or death of larvae was observed with any
antibiotics in the absence of infection prior to therapy trials
(data not shown). Table 3 shows penicillin G to be the most
effective agent in vitro against JBCNJ055 (MIC: 0.18 µg/mL),
however, in vivo larval survival was reduced by 7.5% compared
with controls. Interestingly, Figure 8 shows that the penicillin
G treatment in infected larvae resulted in a rapid onset of
melanisation compared with controls. We have observed a potent
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FIGURE 4 | Mean melanisation score of pooled data, 72 h post inoculation of 10 µL of a range of dilutions from 107 to 103 CFU/mL of Clostridium perfringens
JBCNJ055 and JBFR014. Scoring system is as follows: 1 = healthy, 2 = < 50% melanisation, 3 = > 50% melanisation, 4 = dead. Data shown is pooled from three
distinct repeats and error bars represent standard deviation. Injection with 10 µl of 107 was required to cause potent melanisation resulting in scores higher than 3.
Survival percentages of G. mellonella after inoculation with 10 µL of a range of dilutions 105–10 CFU/mL of C. perfringens.
systemic melanisation in >80% of the larvae in under 60 min
after the treatment dose was administered. Injection of penicillin
G alone was not sufficient to cause this potent reaction. Both
tetracycline and bacitracin were effective against C. perfringens
JBCNJ055 in vitro (MIC: 1.56 µg/mL). In vivo, tetracycline
increased larval survival by 7.5% whereas bacitracin greatly
increased larval survival by a remarkable 28.3% making it the
most effective agent in vivo (Table 3). Unsurprisingly, neomycin
was the least effective in vitro (MIC: 60 µg/mL) alongside a
reduction in larval survival in vivo of 11.3%.
DISCUSSION
Galleria mellonella is becoming a well established in vivo model
for virulence studies of a number of important microbes and is
featuring prominently in the literature as more pathogens are
investigated. The advantages of an insect model over mammalian
studies in terms of ethics, speed and research cost are becoming
apparent with increasing data (Jander et al., 2000). The time
lapse features developed here allows for reduced labor inputs
although it is not possible to physically manipulate the larvae,
a common practice in assessing larval mortality (Peleg et al.,
2009; Harding et al., 2013; Beeton et al., 2015). This has
been overcome in the present study by classifying dead insects
by a melanisation score of 4 (Figure 1) coupled with no
movement for 20 min (2 frames). Time-lapse methodologies,
however, increase precision by reducing intermittent 12 h
observations to 10 min increments. The increase in precision
is of benefit when studying pathogens with rapid disease
progression. Inherent bias in the manual scoring of the
video should be noted but this can be reduced by our
current development of an automated melanisation recognition
system utilizing the time-lapse feature which will allow for
a more robust and standardized scoring system and reduced
processing time.
Galleria mellonella and Clostridium
perfringens
Clostridium perfringens is a ubiquitous organism, with a potential
arsenal of toxins and hydrolytic enzymes associated with
pathogenicity (Petit et al., 1999). The anaerobic pathogen is
economically devastating to the global food industry and is
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FIGURE 5 | Kaplan–Meier survival distributions for dose dependent challenges of JBCNJ055 and JBFR014. ATCC 13124 is avirulent at all dosage levels. Three
repeats of each experiment were pooled. Results were collated as % survival. Strikethrough indicates censored data (unaffected larvae). All levels of infection data
are significant (P < 0.001) [Mantel (cox) log rank test] for both isolates investigated indicating larval survival is based upon the number of bacteria injected.
FIGURE 6 | Comparison of the pathogenicity of cell-free supernatants and washed cultures toward G. mellonella of three distinct C. perfringens isolates with
differing virulence gene composition. Cell-free supernatants were able to cause disease but with varying degrees of potency. Error bars represent standard deviation.
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FIGURE 7 | Comparison of G. mellonella histopathology of control and
infected groups after 72 h incubation after inoculation with 105 CFU of
JBCNJ055. Sections were stained with H+E, Gram-stain and Masson
Fontana (highlighting melanin deposition). Infected groups show distinct loss
of tissue structure, systemic proliferation of Gram-positive bacteria and a large
production of melanin within peripheral tissues indicative of systemic
pathogenicity. Scale bars represent 1 mm. C, Cuticle; M, Muscle layer; N/Nd,
Nodules; Fb, Fat body; Nc, Necrosis.
estimated to cost the poultry sector alone over $6 billion (USD)
per year (Wade et al., 2015). We have shown for the first time
C. perfringens is pathogenic toward G. mellonella larvae although
the degree of pathogenicity is distinct between isolates. The
differences in pathogenicity of isolates may be due to the differing
toxin expression or environmental factors which are thought to
play a major role in mammalian CPAD (Borda-Molina et al.,
2018). Interestingly we have shown that cell-free supernatants
are able to induce disease indicating that soluble factors (toxins)
have pathogenic potential compared with negative controls.
C. perfringens were able to produce larval death at culture inocula
equivalent to other bacteria that have been studied such as
C. jejuni (106 CFU/Larva) Y. pseudotuberculosis (106 CFU/Larva)
and C. difficile (105 CFU/per larva) (Senior et al., 2011; Champion
et al., 2009; Nale et al., 2016), respectively. C. difficile is currently
the only clostridial species which has been investigated in
detail although C. difficle virulence data in the context of the
G. mellonella model is limited. An inoculum size of 105 CFU
of C. difficile isolate CD105LC2 was sufficient to cause 100%
mortality in larvae (Nale et al., 2016). The variance in lethality
between isolates can be seen in other anaerobic enteric pathogens,
however, such as campylobacter spp. (Senior et al., 2011),
Listeria spp. (Martinez et al., 2017), and some strains of enteric
Escherichia spp. (Jønsson et al., 2017). Essential virulence factors
in alternative anaerobes such as Listeria monocytogenes have been
identified such as the extracellular cytolysin, “listerolysin O” that
is essential for virulence, bacterial growth and colonisation of
larvae (Joyce and Gahan, 2010).
CPADs are complex and multifactorial processes are still
poorly understood (Silva and Lobato, 2015). The use of larval
models offers a viable alternative approach for high throughput
screening of potentially pathogenic genotypes of anaerobes.
In the context of C. perfringens, the model would greatly
benefit from further validation studies i.e., the investigation of
immunological aspects of infection such as haemocyte viability
(Bergin et al., 2005), direct toxicological studies and a variety
of histopathological approaches (Harding et al., 2013) to further
our understanding of pathogenic processes. Investigation of oral
inoculation of C. perfringens in G. mellonella remains unexplored
but would offer data on enteric focused pathogenesis and effects
on the microbiome (Mukherjee et al., 2013) that is more
analogous to that of mammalian clostridial enteritis and therefore
a natural further step in the research.
FIGURE 8 | Average melanisation score for larvae infected with 10 µL of 107 JBCNJ055 with a further injection of either penicillin G (2 mg/kg), bacitracin (64 mg/kg),
tetracycline (64 mg/kg), or neomycin (2400 mg/kg). Healthy larvae with no signs of infection were scored 1. Larvae showing nodulation and lateral line melanisation
scored 2. Larvae exhibiting systemic melanisation scored 3. Dead, fully pigmented larvae scored 4. There is a potent increase in melanisation score when penicillin G
is used in response to the infection.
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In the present study, C. perfringens activates the phenoloxidase
pathway although our enzyme activity data suggests no
upregulation of the enzyme in response as seen with other
pathogens (Harding et al., 2013). The larvae may allow for an
in vivo approach to the further understanding of virulence factors
that is challenging in mammals. The potential strength of the
model lies with the ability to demonstrate the in vitro virulence
diversity. Broader studies are required to draw conclusions about
to what extent the mechanism(s) of pathogenicity in larvae relate
to mammalian infections.
In our present study, treatment of the C. perfringens
infection model with antimicrobials appears to broadly correlate
with the in vitro data obtained (Table 3). Penicillin G,
interestingly produces a robust and potent reaction by the
larvae when administered to C. perfringens infected larvae
which was not seen when the antibiotic was administered
to non-infected larvae. Previous studies (Büyükgüzel and
Kalender, 2007) have highlighted that penicillin G induces
high levels of oxidative stress in the midgut of G. mellonella
which may predispose the larvae to disease and may explain
the inefficiency of penicillin in the model which is well known
to be highly effective against C. perfringens. Tetracycline and
bacitracin are both equally effective in vitro against JBCNJ055
but the efficacy of bacitracin in vivo is likely due to its
more bactericidal nature against Gram-positive organisms
in comparison to the broad spectrum but bacteriostatic
tetracycline. The introduction of antifungal compounds
to G. mellonella apparently induces independent immune
responses potentially masking the efficacy of drugs (Kelly
and Kavanagh, 2011). Further research is required here to
ensure that antibacterial drug treatments demonstrate no
compounding effects on larval immunity. Hence, the model
is potentially useful to investigate novel and experimental
treatment approaches in the presence of innate immunological
factors without the expense or ethical implications of working
with mammals. The data obtained may be used to inform
and reduce the number of mammals used for selecting
potential lead compounds.
Our methodological advancements described here will
improve the ability of the model to evaluate the virulence of
pathogens and therapeutic compounds in a more convenient
and less laborious way. The data shown in this study suggest
that virulence of C. perfringens in larvae is distinct and
that future studies to dissect the individual contribution of
toxin genes in virulence are in hand. We consider that the
larvae model will certainly not replace mammalian trials in
physiological studies of disease or mechanisms of host response
but will be a useful adjunct to potentially characterize unknown
pathogenic virulence factors for anaerobic bacteria and perhaps
allow pre-screening of antimicrobials against pathogens before
embarking on expensive and demanding mammalian studies.
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